Literature DB >> 31231706

Endoscopic resection for subepithelial lesions-pure endoscopic full-thickness resection and submucosal tunneling endoscopic resection.

Xiaocen Zhang1, Rani Modayil2, Theresa Criscitelli2, Stavros N Stavropoulos2.   

Abstract

Endoscopic full-thickness resection (EFTR) and submucosal tunneling endoscopic resection (STER) are the frontier of therapeutic endoscopic. These two methods rely on the skillset and equipment of endoscopic submucosal dissection (ESD) while going beyond the boundaries of the gastrointestinal lumen. They are both representatives of natural orifice transluminal endoscopic surgery, with STER being a direct off-shoot of peroral endoscopic myotomy (POEM). Both techniques are designed for the removal of gastrointestinal tumors originating from the muscularis propria but tend to be used in different organs and come with respective challenges. In this review we will go over the history, indication, technique and literature of these two techniques.

Entities:  

Keywords:  Endoscopic resection; gastrointestinal stromal tumor (GIST); leiomyoma; natural orifice transluminal endoscopic surgery; therapeutic endoscopy

Year:  2019        PMID: 31231706      PMCID: PMC6556682          DOI: 10.21037/tgh.2019.05.01

Source DB:  PubMed          Journal:  Transl Gastroenterol Hepatol        ISSN: 2415-1289


  8 in total

Review 1.  Efficacy and safety of gastric exposed endoscopic full-thickness resection without laparoscopic assistance: a systematic review.

Authors:  Granata Antonino; Martino Alberto; Amata Michele; Ligresti Dario; Tuzzolino Fabio; Traina Mario
Journal:  Endosc Int Open       Date:  2020-08-31

Review 2.  Complete laparoscopic-transhiatal removal of duplex benign oesophageal tumour: case report and review of literature.

Authors:  László Andrási; Zoltán Szepes; László Tiszlavicz; György Lázár; Attila Paszt
Journal:  BMC Gastroenterol       Date:  2021-02-02       Impact factor: 3.067

3.  Efficacy of Endoscopic Ultrasound Elastography in Differential Diagnosis of Gastrointestinal Stromal Tumor Versus Gastrointestinal Leiomyoma.

Authors:  Jinlu Guo; Tao Bai; Zhen Ding; Fan Du; Shi Liu
Journal:  Med Sci Monit       Date:  2021-02-04

4.  Retrospective analysis of the outcomes of endoscopic submucosal dissection for the diagnosis and treatment of subepithelial lesions in a center with high expertise.

Authors:  João Santos-Antunes; Margarida Marques; Rui Morais; Francisco Baldaque-Silva; Filipe Vilas-Boas; Pedro Moutinho-Ribeiro; Susana Lopes; Fátima Carneiro; Guilherme Macedo
Journal:  Ann Gastroenterol       Date:  2021-11-10

5.  Colon Sparing Endoscopic Full-Thickness Resection for Advanced Colorectal Lesions: Is It Time for Global Adoption?

Authors:  Zhong-Wei Wu; Chao-Hui Ding; Yao-Dong Song; Zong-Chao Cui; Xiu-Qian Bi; Bo Cheng
Journal:  Front Oncol       Date:  2022-07-13       Impact factor: 5.738

6.  Gastrointestinal exposed endoscopic full-thickness resection in the era of endoscopic suturing: a retrospective single-center case series.

Authors:  Antonino Granata; Alberto Martino; Michele Amata; Dario Ligresti; Mario Traina
Journal:  Wideochir Inne Tech Maloinwazyjne       Date:  2021-03-15       Impact factor: 1.195

7.  Outcomes of endoscopic ultrasound and endoscopic resection of gastrointestinal subepithelial lesions: a single-center retrospective cohort study.

Authors:  Ariosto H Hernandez-Lara; Ana Garcia Garcia de Paredes; Louis M Wong Kee Song; Daniel J Rowan; Rondell P Graham; Michael J Levy; Ferga C Gleeson; Amrit K Kamboj; Kristin C Mara; Barham K Abu-Dayyeh; Vinay Chandrasekhara; Prasad G Iyer; Andrew C Storm; Elizabeth Rajan
Journal:  Ann Gastroenterol       Date:  2021-04-02

Review 8.  Strategies for care of patients with gastrointestinal stromal tumor or soft tissue sarcoma during COVID-19 pandemic: A guide for surgical oncologists.

Authors:  Dario Callegaro; Chandrajit P Raut; Emily Z Keung; Teresa Kim; Cecile Le Pechoux; Javier Martin-Broto; Alessandro Gronchi; Carol Swallow; Rebecca Gladdy
Journal:  J Surg Oncol       Date:  2020-10-06       Impact factor: 2.885

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.